11-113323371-A-G
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_017868.4(TTC12):c.142A>G(p.Met48Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000477 in 1,613,584 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_017868.4 missense
Scores
Clinical Significance
Conservation
Publications
- ciliary dyskinesia, primary, 45Inheritance: AR Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00270 AC: 411AN: 152176Hom.: 4 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000626 AC: 157AN: 250824 AF XY: 0.000420 show subpopulations
GnomAD4 exome AF: 0.000245 AC: 358AN: 1461290Hom.: 3 Cov.: 30 AF XY: 0.000180 AC XY: 131AN XY: 726970 show subpopulations
GnomAD4 genome AF: 0.00271 AC: 412AN: 152294Hom.: 4 Cov.: 32 AF XY: 0.00269 AC XY: 200AN XY: 74474 show subpopulations
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.142A>G (p.M48V) alteration is located in exon 3 (coding exon 2) of the TTC12 gene. This alteration results from a A to G substitution at nucleotide position 142, causing the methionine (M) at amino acid position 48 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at